AR077458A1 - Composiciones de copolimero en bloque de oxido de etileno oxido de butileno - Google Patents

Composiciones de copolimero en bloque de oxido de etileno oxido de butileno

Info

Publication number
AR077458A1
AR077458A1 ARP100102444A ARP100102444A AR077458A1 AR 077458 A1 AR077458 A1 AR 077458A1 AR P100102444 A ARP100102444 A AR P100102444A AR P100102444 A ARP100102444 A AR P100102444A AR 077458 A1 AR077458 A1 AR 077458A1
Authority
AR
Argentina
Prior art keywords
agents
galactomannan
guar
composition according
oxide
Prior art date
Application number
ARP100102444A
Other languages
English (en)
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of AR077458A1 publication Critical patent/AR077458A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/008Polymeric surface-active agents
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/222Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)

Abstract

La presente se refiere a composiciones que comprenden oxido de etileno oxido de butileno y un galactomanano tal como guar. Las composiciones son particularmente apropiadas para aplicaciones oftálmicas tales como desinfeccion y re-humectacion de lentes de contacto. Los métodos para el tratamiento de xeroftalmia usando las composiciones de la presente solicitud también están contemplados. Reivindicacion 1: Una composicion oftálmica acuosa estéril que comprende un copolímero en bloque de oxido de etileno oxido de butileno (EO-BO) de la formula (EO)m(BO)n y un galactomanano. Reivindicacion 2: Una composicion de acuerdo con la reivindicacion 1 donde m tiene un valor promedio de 45 y n tiene un valor promedio de 9 a 18. Reivindicacion 5: Una composicion de acuerdo con la reivindicacion 4 donde dicho guar o derivado guar está seleccionado del grupo que consiste en: Guar natural, guar de hidroxipropilo, galactomanano de hidroxipropil guar. Reivindicacion 8: Una composicion de acuerdo con la reivindicacion 1 donde dicho galactomanano está presente en una concentracion de 0,01 a 2,0% p/v. Reivindicacion 19: Un método para desinfectar una lente de contacto que comprende sumergir la lente en una composicion antimicrobiana que comprende un copolímero en bloque de oxido de etileno oxido de butileno que tiene la formula (EO)m(BO)n y un galactomanano por un tiempo suficiente para desinfectar la lente. Reivindicacion 20: Un método para liberar un agente farmacéutico en el ojo que comprende administrar topicamente al ojo una composicion que comprende uno o más agentes farmacéuticamente activos, un copolímero en bloque de oxido de etileno oxido de butileno de formula (EO)m(BO)n y un galactomanano. Reivindicacion 21: Una composicion de acuerdo con la reivindicacion 20, donde los agentes farmacéuticamente activos están seleccionados del grupo que consiste en agentes antiglaucoma, agentes anti-angiogenesis; agentes anti-infecciosos; agentes anti-inflamatorios; factores de crecimiento; agentes inmunosupresores; y agentes anti-alérgicos.
ARP100102444A 2009-07-07 2010-07-07 Composiciones de copolimero en bloque de oxido de etileno oxido de butileno AR077458A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22359909P 2009-07-07 2009-07-07

Publications (1)

Publication Number Publication Date
AR077458A1 true AR077458A1 (es) 2011-08-31

Family

ID=43427630

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100102444A AR077458A1 (es) 2009-07-07 2010-07-07 Composiciones de copolimero en bloque de oxido de etileno oxido de butileno

Country Status (15)

Country Link
US (1) US9175249B2 (es)
EP (1) EP2451463B1 (es)
JP (1) JP5791600B2 (es)
KR (1) KR101246243B1 (es)
CN (1) CN102548561B (es)
AR (1) AR077458A1 (es)
AU (1) AU2010270628B2 (es)
BR (1) BR112012000506A2 (es)
CA (1) CA2767459C (es)
CL (1) CL2012000061A1 (es)
MX (1) MX2012000456A (es)
RU (1) RU2548789C2 (es)
TW (1) TWI547522B (es)
WO (1) WO2011005864A2 (es)
ZA (1) ZA201200255B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2890182C (en) * 2012-11-19 2020-10-06 Bausch & Lomb Incorporated Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
EP3049119B1 (en) * 2013-09-27 2018-07-11 Novartis AG Compositions and methods for disinfecting and cleaning contact lenses
US9987581B2 (en) 2015-06-22 2018-06-05 Agco International Gmbh Vehicle filter system

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2174761A (en) 1935-04-13 1939-10-03 Ig Farbenindustrie Ag Condensation products derived from hydroxy compounds and method of producing them
GB722746A (en) 1952-06-24 1955-01-26 Wyandotte Chemicals Corp Surface active compounds derived from higher ª‡, ª‰ alkylene oxides
US2674619A (en) 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US2828345A (en) 1955-04-27 1958-03-25 Dow Chemical Co Hydroxypolyoxyethylene diethers of polyoxybutylene glycols
US3050511A (en) 1958-09-15 1962-08-21 Dow Chemical Co Block copolymers of alkenyl aromatic hydrocarbons and alkylene oxides
US3042668A (en) 1960-12-02 1962-07-03 American Molasses Company Modified galactomannan gums and method of preparing same
US3829506A (en) 1971-06-01 1974-08-13 Basf Wyandotte Corp Biodegradable surface active agents having good foam properties and foam stabilizing characteristics
CA1043039A (en) 1973-01-29 1978-11-21 Robert D. Lundberg Multiphase block and graft copolymers comprising a hydrophilic continuous phase and hydrophobic domains
US4130517A (en) 1973-01-29 1978-12-19 Exxon Research & Engineering Co. Multiphase block and graft copolymers comprising a hydrophilic continuous phase and hydrophobic domains
US4104824A (en) 1975-02-27 1978-08-08 Exxon Research & Engineering Co. Multiphase block and graft copolymers comprising a hydrophilic continuous phase and hydrophobic domains
US4218327A (en) 1976-04-05 1980-08-19 Shell Oil Company Stabilizing the viscosity of an aqueous solution of polysaccharide polymer
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
JPS5594901A (en) 1979-01-11 1980-07-18 Nichiden Kagaku Kk Preparation of modified guar gum
US4360451A (en) 1981-08-10 1982-11-23 Basf Wyandotte Corporation Amphoteric surfactant gels
US4447336A (en) 1981-12-18 1984-05-08 Monsanto Company Stabilized galactomannan gum compositions
US4447337A (en) 1982-02-24 1984-05-08 Monsanto Company Stabiized galactomannan gum compositions
US4606831A (en) 1985-06-17 1986-08-19 Monsanto Company Stabilized galactomannan gum compositions
SE458576B (sv) 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
JPS6335606A (ja) 1986-07-30 1988-02-16 Mitsubishi Acetate Co Ltd ガラクトマンナンの精製方法
JPS63101402A (ja) 1986-10-17 1988-05-06 Mitsubishi Acetate Co Ltd ガラクトマンナンの精製法
DE3701509A1 (de) 1987-01-21 1988-08-04 Henkel Kgaa Verfahren zur herstellung von guar-(misch-)ethern aus guarsplits
PT89126B (pt) 1987-12-02 1993-09-30 Colgate Palmolive Co Processo para a preparacao de uma composicao de limpeza suave e de condicionamento para amaciamento da pele, contendo baixos niveis de um agente tensio-activo nao ionico e um acido organico
JPH01247049A (ja) 1988-03-29 1989-10-02 Sumitomo Chem Co Ltd 溶解性の改良されたガラクトマンナンの製造法
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
DE68923444D1 (de) 1988-09-22 1995-08-17 Univ Utah Superoberflächenaktive polymermittel zur verleihung eines widerstandes gegen proteine und zur eliminierung von proteinen.
US5233032A (en) 1990-06-29 1993-08-03 Stein, Hall & Co., Inc. Hydrophobically modified hydroxybutyl ethers of polygalactomannan
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5376693A (en) 1990-08-07 1994-12-27 Mediventures Inc. Thermo-irreversible gel corneal contact lens formed in situ
JPH08842B2 (ja) 1991-05-22 1996-01-10 信越化学工業株式会社 多糖類の精製方法
EP0557627A1 (en) 1992-02-24 1993-09-01 TAIYO KAGAKU Co., LTD. Limitedly enzyme-hydrolyzed polysaccharide and method for its production
JP2729722B2 (ja) 1992-03-02 1998-03-18 三菱レイヨン株式会社 精製ガラクトマンナンの製造方法
JPH05239105A (ja) 1992-03-02 1993-09-17 Mitsubishi Rayon Co Ltd 精製ガラクトマンナンの製造方法
DK0639070T4 (da) 1992-05-06 2010-12-13 Alcon Lab Inc Anvendelse af borat-polyolkomplekser til ophtalmiske præparater
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
JPH09502029A (ja) 1993-06-18 1997-02-25 ポリマー テクノロジー コーポレイション コンタクトレンズを清浄および湿潤するための組成物
US5370744B1 (en) 1993-08-27 1999-11-09 Alcon Lab Inc Process for cleaning and disinfecting contact lenses
US5631005A (en) 1994-09-21 1997-05-20 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
US5489674A (en) 1994-06-09 1996-02-06 Rhone-Poulenc Inc. Guar gum composition and process for making it
EP0686643B1 (en) 1994-06-09 2001-06-06 Rhodia Inc. Guar gum composition and process for making it
US5536825A (en) 1994-06-09 1996-07-16 Rhone-Poulenc Inc. Derivatized guar gum composition and process for making it
EP0698660B1 (en) 1994-08-22 2001-09-26 Kao Corporation Detergent composition for hard surface
US5602241A (en) 1995-03-14 1997-02-11 Shin-Etsu Chemical Co., Ltd. Method for purifying polysaccharides
US6063402A (en) 1995-06-07 2000-05-16 Venture Lending, A Division Of Cupertino National Bank Purified galactomannan as an improved pharmaceutical excipient
CH691026A5 (de) 1995-09-28 2001-04-12 Meyhall Chemical Ag Rhone Poul Verfahren zur Herstellung von reinem Guarkernmehl.
US6004923A (en) 1995-10-27 1999-12-21 Basf Aktiengesellschaft Fatty acid derivatives and their use as surfactants in detergents and cleaners
JP4030603B2 (ja) 1995-11-02 2008-01-09 ノボザイムス アクティーゼルスカブ アルカリプロテアーゼ、その製造方法、用途及びそのプロテアーゼを生産する微生物
WO1997025354A1 (en) 1996-01-05 1997-07-17 Rhone-Poulenc Inc. Modified guar, prepared by high shear treatment under acidic conditions at elevated temperature
US5756720A (en) 1996-10-25 1998-05-26 Rhodia Inc. Derivatized guar gum composition including nonionic and cationic groups which demonstrate excellent solution clarity properties
ATE230764T1 (de) 1996-10-25 2003-01-15 Rhodia Zusammensetzung auf basis von derivatisiertem guargummi, welche nichtionische und kationische gruppen enthält, und die daraus hergestellten lösungen sehr klar und in reinigungsmitteln verwendbar sind
DE69713388T2 (de) 1996-12-13 2002-10-31 Alcon Lab Inc Verwendung von niedermolekularen aminoalkoholen in ophthalmologischen präparaten
US6214596B1 (en) 1996-12-18 2001-04-10 Alcon Laboratories, Inc. Liquid enzyme compositions and methods of use in contact lens cleaning and disinfecting systems
US5997907A (en) 1997-03-12 1999-12-07 Rhodia Inc. Enhancement of guar solution stability
CA2296080C (en) 1997-07-29 2005-02-01 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate
ES2227331T3 (es) * 1997-07-29 2005-04-01 Alcon Laboratories, Inc. Soluciones de acondicionamiento para el cuidado de las lentes de contacto duras.
ZA9811445B (en) 1997-12-19 1999-08-16 Alcon Lab Inc Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
US6656504B1 (en) 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
MY128134A (en) 2000-09-28 2007-01-31 Novartis Ag Compositions and methods for cleaning contact lenses
US8728445B2 (en) * 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
DE10135060A1 (de) 2001-07-18 2003-02-06 Noveon Ip Holdings Corp Galactomannan mit verändertem Mannose zu Galactose Verhältnis
TW200300448A (en) 2001-11-21 2003-06-01 Novartis Ag Conditioning solution for contact lenses
DE10241878A1 (de) 2002-09-10 2004-03-11 Ecolab Gmbh & Co. Ohg Reinigung von Fahrzeugen
US20040241130A1 (en) 2002-09-13 2004-12-02 Krishnan Tamareselvy Multi-purpose polymers, methods and compositions
US7378479B2 (en) 2002-09-13 2008-05-27 Lubrizol Advanced Materials, Inc. Multi-purpose polymers, methods and compositions
ITTO20020809A1 (it) * 2002-09-17 2004-03-18 St Microelectronics Srl Micropompa, in particolare per un dispositivo integrato di analisi del dna.
TW200503762A (en) 2003-05-09 2005-02-01 Toho Chem Ind Co Ltd Cation-modified galactomannan polysaccharide and cosmetic composition containing the same
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7195065B2 (en) 2004-08-05 2007-03-27 Baker Hughes Incorporated Stabilizing crosslinked polymer guars and modified guar derivatives
US7629386B2 (en) 2004-08-26 2009-12-08 Bausch + Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
RU2285511C2 (ru) * 2004-10-13 2006-10-20 НИИ ГБ им. Гельмгольца Средство для лечения синдрома сухого глаза
US20060229219A1 (en) * 2005-04-11 2006-10-12 Advanced Medical Optics, Inc. Borate-polyol mixtures as a buffering system
US7282178B2 (en) 2005-06-03 2007-10-16 Bausch & Lomb Incorporated Composition and method for cleaning lipid deposits on contact lenses
TWI434926B (zh) * 2006-12-11 2014-04-21 Alcon Res Ltd 眼用組成物中聚氧化乙烯-聚氧化丁烯(peo-pbo)嵌段共聚物之使用
AR066901A1 (es) * 2007-05-18 2009-09-23 Alcon Mfg Ltd Composiciones fodfolipidicas para elcuidado de lentes de contacto y conservacion de composiciones farmaceuticas
US20090132294A1 (en) * 2007-11-15 2009-05-21 Haines Samuel H Method for ranking driver's relative risk based on reported driving incidents
TWI526213B (zh) 2008-04-26 2016-03-21 愛爾康研究有限公司 聚合性人工淚液系統
KR20110095857A (ko) 2008-09-10 2011-08-25 칼립시스, 인코포레이티드 질환의 치료를 위한 히스타민 수용체의 헤테로시클릭 억제제

Also Published As

Publication number Publication date
MX2012000456A (es) 2012-02-28
US9175249B2 (en) 2015-11-03
EP2451463B1 (en) 2018-11-07
BR112012000506A2 (pt) 2017-05-16
CN102548561B (zh) 2016-03-16
WO2011005864A2 (en) 2011-01-13
US20110008276A1 (en) 2011-01-13
KR20120028994A (ko) 2012-03-23
CA2767459C (en) 2018-04-10
CA2767459A1 (en) 2011-01-13
CL2012000061A1 (es) 2012-10-19
RU2548789C2 (ru) 2015-04-20
AU2010270628A1 (en) 2012-02-02
ZA201200255B (en) 2013-03-27
JP2012532878A (ja) 2012-12-20
RU2012103982A (ru) 2013-08-20
KR101246243B1 (ko) 2013-03-22
AU2010270628B2 (en) 2013-12-19
JP5791600B2 (ja) 2015-10-07
TWI547522B (zh) 2016-09-01
EP2451463A2 (en) 2012-05-16
WO2011005864A3 (en) 2011-04-28
TW201107414A (en) 2011-03-01
CN102548561A (zh) 2012-07-04

Similar Documents

Publication Publication Date Title
ES2443548T3 (es) Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
AR031135A1 (es) Composiciones de antibiotico topico para el tratamiento de infecciones oculares
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
AR062046A1 (es) Soluciones oftalmicas
BR112012021638A2 (pt) composição livre de conservantes estéril ótica farmacêutica na forma de uma solução aquosa clara.
JP6190503B2 (ja) 水性眼科組成物
MX2012012846A (es) Composicion oftalmica.
RU2014148758A (ru) Офтальмологические композиции с улучшенной защитой от обезвоживания и удерживанием
KR20100135813A (ko) 개선된 효능을 나타내는 인산염 완충된 안과용 용액
JP2017190348A (ja) 水性眼科組成物
AR077458A1 (es) Composiciones de copolimero en bloque de oxido de etileno oxido de butileno
US9138481B2 (en) Cellulosic gel composition with improved viscosity stability
ES2939641T3 (es) Solvente anti-Acanthamoeba para lentes de contacto
JPWO2010010689A1 (ja) コンタクトレンズ用液剤
WO2013008715A1 (ja) 水性眼科組成物
JP2016041773A (ja) ホスホニウム抗菌剤を含む薬学的組成物
NZ596035A (en) METHOD AND COMPOSITION FOR TREATING MACULAR DEGENERATION using 15-keto-prostaglandin such as 13,14-dihydro-15-keto-20-ethyl-prostagladin F2-alpha isopropyl ester
JP5587359B2 (ja) コンタクトレンズ用組成物
JP2011111441A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
ES2543431T3 (es) Concentrados agroquímicos que contienen Isopirazam
JP2012532878A5 (es)
JP5650864B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
AU2010236505B2 (en) Aqueous ophthalmic compositions containing anionic therapeutic agents
JP2012198428A (ja) コンタクトレンズ用組成物
BR112014013564A2 (pt) composição farmacêutica tópica destinada à aplicação ao olho, ouvido ou nariz

Legal Events

Date Code Title Description
FB Suspension of granting procedure